Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Updates in Surgery|September 7, 2021
Colectomy risk score predicts pouchitis in patients with ulcerative colitisAkiyoshi Ikebata, Koji Okabayashi, Masashi Tsuruta, et al.
Surgery Today|August 2, 2015
Transanal drainage tube placement to prevent anastomotic leakage following colorectal cancer surgery with double stapling reconstructionMutsuhito Matsuda, Masashi Tsuruta, Hirotoshi Hasegawa, et al.
The Journal of Surgical Research|April 1, 2014
Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancerHiroto Kikuchi, Hiroshi Yagi, Hirotoshi Hasegawa, et al.
Surgical Endoscopy|August 12, 2021
Surgical glove perforation during laparoscopic colorectal proceduresShinsei Matsuoka, Takayuki Kondo, Ryo Seishima, et al.
Clinics and Research in Hepatology and Gastroenterology|January 19, 2016
Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9(+) cancer stem cells in ulcerative colitis-related cancerRyo Seishima, Koji Okabayashi, Osamu Nagano, et al.
Surgery Today|October 21, 2018
The impact of the mesorectal apparent diffusion coefficient value on surgical difficulty in laparoscopic anterior resection for rectal cancerHirofumi Suzumura, Masashi Tsuruta, Hirotoshi Hasegawa, et al.
International Journal of Surgery Case Reports|October 9, 2016
Laparoscopic totally extra-peritoneal hernia repair for bilateral Spigelian hernias and coincident inguinal hernia: A case reportShimpei Matsui, Nobuhiro Nitori, Ayu Kato, et al.
Surgery Today|June 29, 2021
Impact of intraoperative hypocapnia on postoperative complications in laparoscopic surgery for colorectal cancerSatoru Morita, Masashi Tsuruta, Koji Okabayashi, et al.
Surgery|April 27, 2021
Lymph node metastasis is strongly associated with lung metastasis as the first recurrence site in colorectal cancerYujin Kato, Kohei Shigeta, Koji Okabayashi, et al.
International Journal of Cancer|April 11, 2016
Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancerKohei Shigeta, Hirotoshi Hasegawa, Koji Okabayashi, et al.
Pageof 6